Experimental Flow Field Assessment – Digital Particle Image Velocimetry (DPIV)

Using Digital Particle Image Velocimetry (DPIV),  pulsatile flow conditions in the immediate vicinity of the device can be analyzed to determine the viability of cardiovascular devices meeting regulatory standards. Triggers for disease (such as shear stresses and regions of stagnation) can be quantified with a high degree of accuracy. Advanced methods, including proper orthogonal decomposition, also capture the implicit fluid mechanical phenomenon of interest.

Test Procedure

ViVitro Labs testing provides 2D high-speed information regarding the Quantitative and Qualitative nature of the flow surrounding a device. Qualitative outputs include flow assessment based on particle streaks with assessment and description of any occurrences of flow separation, flow stasis, vortex formation, jet nature, regurgitant and other fluid mechanical phenomenon. Quantitative outputs include velocity, shear stresses, and particle residence times during various phases of the cardiac cycle. Stagnant flow may induce potential blood clot formation during heart valve operation.

High flow velocities in the vicinity of the device may induce potential haemolysis and platelet activation.


Measured Parameters

  • Velocity
  • Shear stress (viscous shear stress, Reynolds shear stress)
  • Regions of stagnation
  • Qualitative analysis: Turbulent flow region, flow separation, vortex formation, jets
  • Calculated particle residence time (if required)


  • Transcatheter valves; TAVI, TMVR
  • Biological, Polymeric, Mechanical valves: Rigid or soft
  • Venous valves and conduits
  • Valvular conduits
  • Vena Cava Filters
  • Assist ventricular devices
  • Any device implant in flow models

Service Levels

Applicable Standards

  • ISO 5840-2:2021
    Cardiovascular implants — Cardiac valve prostheses — Part 2: Surgically implanted heart valve substitutes

  • ISO 5840-3:2021
    Cardiovascular implants — Cardiac valve prostheses — Part 3: Heart valve substitutes implanted by transcatheter techniques

Related Tests


Digital Particle Image Velocimetry (DPIV)- Flow Visualization Digital Particle Image Velocimetry (DPIV)- Flow Visualization Animation

ViVitro Labs Advantages

Many companies look to academia to handle their testing needs due to the reduced cost. With ViVitro Laboratory Services you gain the following advantages:

ISO 17025 Accredited
For studies used for regulatory approval this is a must. Victoria and Marseille labs accredited by A2LA.

Test Method Validation
The FDA and Notified Bodies around the world are requiring evidence of Test Method Validation. ViVitro Labs has invested significant resources to validate the most common test methods that are not ISO 17025 accredited. We continue to work closely with device manufacturers and share the burden with our clients to validate other specific test methods that are less in demand.

We understand how critical your timelines are. Our expertise and experience ensure your schedule is met and our commitments are delivered on time.

Free Initial Consultations
All of our studies are scoped via no-cost, no obligation, collaborative consultation.

Guaranteed Confidentiality
We happily provide Non-Disclosure Agreements for all services, including initial consultation.

Join over 5000 cardiovascular device professionals who receive our testing and engineering insights and tips every month.